Outcomes of Maternal Newborn Dyads After Maternal SARS-Cov-2

As SARS-Cov-2 is a novel pathogen recently identified to cause infection in humans, there is limited data available on both maternal and neonatal outcomes, and whether there is possibility of vertical transmission after a pregnant women gets infected with SARS-Cov-2. Due to paucity of published literature and inconclusive outcomes among mothers confirmed SARS-Cov-2 infection and their newborns, there is an urgent need for studies to better understand the impact of maternal infection with SARS-Cov-2 on both mothers and newborns. To this end, we aimed to study the characteristics and outcomes of maternal-newborn dyads with confirmed SARS-Cov-2 in mothers at four major New York City metropolitan area hospitals.

Outcomes of Maternal-Newborn Dyads After Maternal SARS-Cov-2
Size: 5.6 MB